These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9554071)

  • 1. Innate and cell-mediated immune responses to Cryptosporidium parvum.
    Theodos CM
    Adv Parasitol; 1998; 40():87-119. PubMed ID: 9554071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in cryptosporidiosis: the immune response.
    Riggs MW
    Microbes Infect; 2002 Aug; 4(10):1067-80. PubMed ID: 12191657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
    Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
    Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune responses against Cryptosporidium parvum infection.
    McDonald V; Korbel DS; Barakat FM; Choudhry N; Petry F
    Parasite Immunol; 2013 Feb; 35(2):55-64. PubMed ID: 23173616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice.
    Rogers KA; Rogers AB; Leav BA; Sanchez A; Vannier E; Uematsu S; Akira S; Golenbock D; Ward HD
    Infect Immun; 2006 Jan; 74(1):549-56. PubMed ID: 16369011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targets for detection and immunotherapy in Cryptosporidium parvum.
    Boulter-Bitzer JI; Lee H; Trevors JT
    Biotechnol Adv; 2007; 25(1):13-44. PubMed ID: 17055210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host immune response to Cryptosporidium parvum infection.
    Petry F; Jakobi V; Tessema TS
    Exp Parasitol; 2010 Nov; 126(3):304-9. PubMed ID: 20685209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptosporidiosis: host immune responses and the prospects for effective immunotherapies.
    McDonald V
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1077-86. PubMed ID: 22029525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of surface antigen-1 (SA-1) immune lymphocyte subsets and naive cell subsets in protecting scid mice from initial and persistent infection with Cryptosporidium parvum.
    Tatalick LM; Perryman LE
    Vet Immunol Immunopathol; 1995 Jul; 47(1-2):43-55. PubMed ID: 8533299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection.
    Aguirre SA; Perryman LE; Davis WC; McGuire TC
    J Immunol; 1998 Aug; 161(4):1891-900. PubMed ID: 9712058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirements for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice.
    Chen W; Harp JA; Harmsen AG
    Infect Immun; 1993 Sep; 61(9):3928-32. PubMed ID: 8103040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferon.
    Barakat FM; McDonald V; Foster GR; Tovey MG; Korbel DS
    J Infect Dis; 2009 Nov; 200(10):1548-55. PubMed ID: 19821721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus infection and cryptosporidiosis: protective immune responses.
    Flanigan TP
    Am J Trop Med Hyg; 1994; 50(5 Suppl):29-35. PubMed ID: 8203720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of Cryptosporidium parvum-specific cytokine responses in healing and nonhealing murine models of C. parvum infection.
    Singh I; Theodos C; Li W; Tzipori S
    Parasitol Res; 2005 Oct; 97(4):309-17. PubMed ID: 16052360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice.
    McDonald V; Bancroft GJ
    Parasite Immunol; 1994 Jun; 16(6):315-20. PubMed ID: 7970868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divalent Cp15-23 vaccine enhances immune responses and protection against Cryptosporidium parvum infection.
    Liu K; Zai D; Zhang D; Wei Q; Han G; Gao H; Huang B
    Parasite Immunol; 2010 May; 32(5):335-44. PubMed ID: 20500662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cytokines in the pathogenesis of Cryptosporidium infection.
    Lean IS; McDonald V; Pollok RC
    Curr Opin Infect Dis; 2002 Jun; 15(3):229-34. PubMed ID: 12015455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo.
    Doyle PS; Crabb J; Petersen C
    Infect Immun; 1993 Oct; 61(10):4079-84. PubMed ID: 8406795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immune responses in cryptosporidiosis.
    Borad A; Ward H
    Future Microbiol; 2010 Mar; 5(3):507-19. PubMed ID: 20210556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection.
    Theodos CM; Sullivan KL; Griffiths JK; Tzipori S
    Infect Immun; 1997 Nov; 65(11):4761-9. PubMed ID: 9353062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.